Do Analysts Agree on Aurora Cannabis Inc (ACB) Stock's Target Price?

Friday, February 28, 2020 12:14 PM | InvestorsObserver Analysts

Analysts who follow Aurora Cannabis Inc (ACB) on average expect it to climb 30.15% over the next twelve months. Those same analysts give the stock an average rating of Hold.

That average rating puts Aurora Cannabis Inc higher than 6 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 2.9
Wall Street analysts are rating ACB a today. Find out what this means to you and get the rest of the rankings on ACB!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.

InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Aurora Cannabis Inc Stock Today?

Aurora Cannabis Inc (ACB) stock is trading at $1.36 as of 12:03 PM on Friday, Feb 28, a drop of -$0.10, or -6.55% from the previous closing price of $1.45. The stock has traded between $1.32 and $1.40 so far today. Volume today is light. So far 13,695,876 shares have traded compared to average volume of 31,743,589 shares.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Is Global Cord Blood Corp (CO) Stock a Great Value?

Denali Therapeutics Inc (DNLI) Stock Climbs 10.58% This Week; Should You Buy?

Should Replimune Group Inc (REPL) Stock be in Your Portfolio?

Should You Buy AcelRx Pharmaceuticals Inc (ACRX) Stock?

Sector Update: Health Care Stocks Slipping in Late Trade

Related Companies